In CRC preclinical and clinical studies, tumor suppressors such as HCRP-1 [60] and transcription factors like KLF5 have been implicated in promoting survival under detachment conditions, suggesting their potential role as novel targets in CRC progression and metastatic cascade inhibition [10, 61, 62]. Here, KLF5 is linked to colorectal carcinoma.